All News #Library
Others
Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO
20 Dec 2023 //
BUSINESSWIRE
Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
28 Feb 2022 //
BUSINESSWIRE
Edenbridge Pharmaceuticals Announces U.S. FDA Approval of DARTISLA ODT
17 Dec 2021 //
BIOSPACE
FDA Approves Edenbridge`s DARTISLA ODT Orally Disintegrating Tablets
17 Dec 2021 //
BUSINESSWIRE